Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement

Journal of Investigative Medicine

Volumn 56, Issue 8, 2008, Pages 1023-1027

  Chang, Wun Ling ^b   Corate, Lalaine M ^a   Sinclair, James M ^a   Van Der Heyde, Henri C ^b  

^a SCRIPPS MEMORIAL HOSPITAL   (United States)

^b La Jolla Infectious Disease Institute   (United States)

Author keywords

Nitric oxide; Sickle cell; Thrombocytosis; Vaso occlusion

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CEFTRIAXONE; CREATININE; HEMOGLOBIN A2; HEMOGLOBIN F; HEMOGLOBIN S; HYDROCODONE; HYDROXYUREA; IBUPROFEN; LACTATE DEHYDROGENASE; LEVOFLOXACIN; METHEMOGLOBIN; MORPHINE; NITRIC OXIDE; PARACETAMOL; PIPERACILLIN PLUS TAZOBACTAM;

ACUTE CHEST SYNDROME; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATELECTASIS; BACKACHE; BILIRUBIN BLOOD LEVEL; BLOOD VESSEL OCCLUSION; BODY TEMPERATURE; BONE PAIN; CASE REPORT; CREATININE BLOOD LEVEL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROPHORESIS; FEMALE; FEVER; HEART LEFT VENTRICLE HYPERTROPHY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYDRATION; HYPERTENSION; HYPOTENSION; JEHOVAH'S WITNESS; KIDNEY INJURY; LACTATE DEHYDROGENASE BLOOD LEVEL; LEG PAIN; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LUNG ARTERY PRESSURE; LUNG INFECTION; LUNG INFILTRATE; METHEMOGLOBINEMIA; MITRAL VALVE REGURGITATION; MULTIPLE ORGAN FAILURE; OXYGEN THERAPY; PARTIAL THROMBOPLASTIN TIME; PATIENT CONTROLLED ANALGESIA; PROTHROMBIN TIME; PULMONARY HYPERTENSION; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SORE THROAT; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT FAILURE; TRICUSPID VALVE REGURGITATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; INHALATIONAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ADULT; ANEMIA, SICKLE CELL; FEMALE; HUMANS; NITRIC OXIDE;

EID: 58149341768     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31818cb612     Document Type: Article

References (12)

1. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21:37-47.
2. Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383-1389.
3. Hrinczenko BW, Alayash AI, Wink DA, et al. Effect of nitric oxide and nitric oxide donors on red blood cell oxygen transport. Br J Haematol. 2000;110:412-419.
4. Morris CR, Kato GJ, Poljakovic M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005;294:81-90.
5. Weiner DL, Brugnara C. Hydroxyurea and sickle cell disease: a chance for every patient. JAMA. 2003;289: 1692-1694.
6. Weiner DL, Hibberd PL, Betit P, et al. Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. JAMA. 2003;289:1136-1142.
7. Atz AM, Wessel DL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology. 1997; 87:988-990.
8. Sullivan KJ, Goodwin SR, Evangelist J, et al. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med. 1999; 27:2563-2568.
9. Moro MA, Russel RJ, Cellek S, et al. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A. 1996;93:1480-1485.
10. Olivia M. The Effect of Oxy-MP4, CO-MP4, and DPTA on the Filterability of Sickle Red Blood Cells During Continuous Deoxygenation. Master of Science Thesis, University of California, San Diego, 2005.
11. Kleinbongrad P, Schulz R, Rassaf T, et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood. 2006;107:2943-2951.
12. Bernini JC, Rogers ZR, Sandler ES, et al. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood. 1998;92:3082-3089.